Skip to content

MDMA: all studies

Page 133 of 346: studies 1,321 to 1,330 of 3,454, newest first. Back to the MDMA overview

Research

Test–re‐test reliability of DSM‐IV adopted criteria for 3,4‐methylenedioxymethamphetamine (MDMA) abuse and dependence: a cross‐national study

Addiction August 4, 2009 Linda B. Cottler, Kit Sang Leung, Arbi Ben Abdallah 56 citations

ABSTRACT Aims This study evaluated the prevalence and reliability of DSM‐IV adopted criteria for 3,4‐methylenedioxymethamphetamine (MDMA) abuse and dependence with a purpose to determine whether it is best conceptualized within the category of hallucinogens, amphetamines or its own category. Design Test–re‐test study. Participants MDMA users (life‐time use >5 times) were recruited in St Louis,...

DOI: 10.1111/j.1360-0443.2009.02649.x (opens in new tab) MDMA Substance abuse Clinical psychology Test biology

Administration of MDMA to ethanol-deprived rats increases ethanol operant self-administration and dopamine release during reinstatement.

The International Journal of Neuropsychopharmacology August 2009 Guillermo Moreno-Sanz, Esther O'Shea, Laura Orío et al.

Recreational use of (±)-3,4-methylenedioxymethamphetamine (MDMA, ecstasy) is often associated with other drugs, among which ethanol (EtOH) is one of the most common. However, little is known about how neurochemical sensitization produced by MDMA can modulate EtOH abuse. In this study we used EtOH operant self-administration tasks to investigate the effect of several low doses (0.33, 1.0 and 3.0...

Differential changes in mesolimbic dopamine following contingent and non-contingent MDMA self-administration in mice.

Psychopharmacology August 2009 María Juliana Orejarena, Fernando Berrendero, Rafaël Maldonado et al.

There is evidence demonstrating changes in dopamine (DA) transmission in the nucleus accumbens (NAc) related to contingent versus non-contingent drug administration. The aim of this study was to evaluate basal and 3,4-methylenedioxymethamphetamine (MDMA)-stimulated DA levels in the NAc of mice that had previously received contingent and non-contingent infusions of MDMA. Contingent mice were...

Equivalent effects of acute tryptophan depletion on REM sleep in ecstasy users and controls.

Psychopharmacology July 8, 2009 Robin Carhart-Harris, David Nutt, Marcus R. Munafò et al.

Introduction: This study sought to test the association between 3,4-methylenedioxymethamphetamine use, serotonergic function and sleep. Materials and methods: Ambulatory polysomnography was used to measure three nights sleep in 12 ecstasy users and 12 controls after screening (no intervention), a tryptophan-free amino acid mixture (acute tryptophan depletion (ATD)) and a tryptophan-supplemented...

DOI: 10.1007/s00213-009-1595-3 (opens in new tab) Full text (opens in new tab) Humans Substance-related disorders N-methyl-3,4-methylenedioxyamphetamine Tryptophan +9

Reduced memory and attention performance in a population-based sample of young adults with a moderate lifetime use of cannabis, ecstasy and alcohol.

Journal of Psychopharmacology July 2009 F Indlekofer, M Piechatzek, M Daamen et al.

Regular use of illegal drugs is suspected to cause cognitive impairments. Two substances have received heightened attention: 3,4-methylenedioxymethamphetamine (MDMA or 'ecstasy') and delta-9-tetrahydrocannabinol (THC or 'cannabis'). Preclinical evidence, as well as human studies examining regular ecstasy consumers, indicated that ecstasy use may have negative effects on learning, verbal memory...

Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration

Social Neuroscience June 25, 2009 Glenn Dumont, Fred C.g.j. Sweep, R. van der Steen et al. 238 citations

MDMA (3,4-methylenedioxymethamphetamine or "ecstasy") is a recreationally used drug with remarkable and characteristic prosocial effects. In spite of abundant attention in the scientific literature, the mechanism of its prosocial effects has not been elucidated in humans. Recently, research in animals has suggested that the neuropeptide oxytocin may induce these effects. In a double blind,...

Hallucinogen-related disorders in a national sample of adolescents: the influence of ecstasy/MDMA use.

Drug and Alcohol Dependence June 4, 2009 Li-Tzy Wu, Christopher L. Ringwalt, Roger D Weiss et al.

Aims: To present the prevalence and correlates of hallucinogen use disorders (HUDs: abuse or dependence) and subthreshold dependence. Methods: The study sample included adolescents aged 12-17 years (N=55,286) who participated in the National Survey on Drug Use and Health (2004-2006). Data were collected with a combination of computer-assisted personal interviewing and audio computer-assisted...

DOI: 10.1016/j.drugalcdep.2009.04.014 (opens in new tab) Full text (opens in new tab) Humans Substance-related disorders N-methyl-3,4-methylenedioxyamphetamine Hallucinogens +9

Direct Comparison of (±) 3,4-Methylenedioxymethamphetamine (“Ecstasy”) Disposition and Metabolism in Squirrel Monkeys and Humans

Therapeutic Drug Monitoring June 1, 2009 Melanie Mueller, Erin A Kolbrich, Frank T. Peters et al.

The present study compared the disposition and metabolism of the recreational drug (±) 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) in squirrel monkeys and humans because the squirrel monkey has been extensively studied for MDMA neurotoxicity. A newly developed liquid chromatography-mass spectrometric procedure for simultaneous measurement of MDMA, 3,4-dihydroxymethamphetamine,...

Discriminative stimulus effects of 3,4-methylenedioxymethamphetamine and its enantiomers in mice: pharmacokinetic considerations.

Journal of Pharmacology and Experimental Therapeutics June 2009 William E Fantegrossi, Naoki Murai, Brian O Mathúna et al.

3,4-Methylenedioxymethamphetamine (MDMA) is a drug of abuse with mixed stimulant- and hallucinogen-like effects. The aims of the present studies were to establish discrimination of S(+)-MDMA, R(-)-MDMA, or their combination as racemic MDMA in separate groups of mice to assess cross-substitution tests among all three compounds, to determine the time courses of the training doses, to assess...

MDMA reinstates cocaine-seeking behaviour in mice.

European Neuropsychopharmacology June 2009 José Manuel Trigo, María Juliana Orejarena, Rafaël Maldonado et al.

MDMA effects are mediated by monoaminergic systems, which seem to play a central role in cocaine craving and relapse. CD1 mice trained to self-administer cocaine (1 mg/kg/infusion) underwent an extinction procedure in which the cues contingent with drug self-administration remained present. Mice achieving extinction were injected with MDMA (10 mg/kg), d-amphetamine (1 and 2 mg/kg) or saline and...